Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy

The TABAC STOP ORL POUMON study is a prospective, single-center observational study aiming to understand factors influencing long-term smoking cessation in patients treated for head and neck or lung cancer. Tobacco is a leading cause of death and disease, particularly in areas like Hauts-de-France with high smoking rates.

Eligible patients, undergoing radiotherapy or chemoradiotherapy, are enrolled during the final week of treatment, completing questionnaires assessing nicotine dependence and alcohol use. Follow-ups are scheduled at 1, 6, and 12 months, through clinic visits or phone interviews.

The primary endpoint is the proportion of patients who remain smoke-free at 6 months. Secondary endpoints include factors influencing smoking cessation, reasons for relapse, and changes in nicotine and alcohol dependence. The study will enroll 100 patients, expecting 81 evaluable cases, with data quality ensured through regular checks and source verification.

Inclusion criteria

• Patient aged 18 years or older
• Diagnosed with head and neck cancer or lung cancer
• Undergoing curative treatment with chemoradiotherapy, radiotherapy alone, or stereotactic radiotherapy
• Current or former smoker
• Patient covered by a social security scheme
• Patient informed and having given consent for data collection

Patients with human papillomavirus (HPV) may also be included

Exclusion criteria

• Patient receiving palliative treatment
• Patient under guardianship or curatorship

Study Exit Criteria :

• Protocol-defined exit : After the 12-month consultation

Early exit :

• Withdrawal of consent for data collection
• Death of the patient